Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...

Thinking about diving into the world of programming languages? It can seem a bit much at first, right? Well, there’s a book out there, the 12th edition of ‘Concepts of Programming Languages,’ that a ...

The companies, which are yet to announce the approval, did not immediately respond to Reuters' request for a comment. Sun Pharma, which is India's largest drugmaker by revenue, on Friday announced ...

Forbes contributors publish independent expert analyses and insights. I am an MIT Senior Fellow & Lecturer, 5x-founder & VC investing in AI Here we are in a time when the world has discarded previous ...

WASHINGTON, Dec 3 (Reuters) - AT&T (T.N), opens new tab and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of orchestrating an ...

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs to market in a press conference on Wednesday. The Food and Drug ...

Adderall is a central nervous system stimulant that's prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...

The Food and Drug Administration approved a new generic version of a pill used to terminate pregnancies, a decision that comes as the Department of Health and Human Services reviews the drug’s safety.

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma industry. Most Indian drugmakers sell generic pharmaceutical ...